L-citrulline Injection in Patients Aged 6-21 Years Old with Sickle Cell Disease Presenting with Vaso-Occlusive Crisis (VOC)

NCT04852172 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

30

Enrollment

INDUSTRY

Sponsor class

Stopped Impacted by viraemia resulting in higher than expected admissions

Conditions

Acute Vaso Occlusive Crisis (VOC)

Interventions

DRUG: L-citrulline
OTHER: D5 1/2NS

Sponsor

Asklepion Pharmaceuticals, LLC